Related Experiment Video
Updated: Aug 9, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Risk Factors for Infection and Mortality Associated With Stenotrophomonas maltophilia Bloodstream Infections in
Nimet Melis Bilen1, Zumrut Sahbudak Bal1, Gizem Güner Özenen1
1From the Department of Pediatrics, Division of Infectious Disease, Medical School of Ege University, Izmir, Turkey.
Introduction:
The increasing incidence of Stenotrophomonas maltophilia ( S. maltophilia ) infections raises concern because of the high fatality/case ratio. This study aimed to evaluate the risk factors for infection and mortality associated with S. maltophilia bloodstream infections (BSIs) in children and compare them with Pseudomonas aeruginosa BSIs.
Methods:
All BSIs caused by S. maltophilia (n:73) and P. aeruginosa (n:80) were enrolled in this study between January 2014 and December 2021 at the Medical School of Ege University.
Results:
Previous Pediatric Intensive Care Unit (PICU) admission, prior glycopeptide, and carbapenem use were significantly more common in patients with S. maltophilia BSIs ( P = 0.044, P = 0.009, and P = 0.001, respectively) than with P. aeruginosa BSIs. C-reactive protein (CRP) levels were significantly higher in S. maltophilia BSIs ( P = 0.002). Multivariate analysis showed that prior carbapenem use was associated with S. maltophilia BSIs ( P = 0.014, adjusted odds ratio [AOR]: 2.710; 95% confidence interval [CI]: 1.225-5.992). PICU admission because of BSI, prior carbapenem and glycopeptide use, neutropenia, and thrombocytopenia were significantly more common in patients with mortality because of S. maltophilia BSIs ( P < 0.001, P = 0.010, P = 0.007, P = 0.008, P = 0.004, respectively), while only PICU admission because of BSI, and prior glycopeptide use were significant in multivariate analysis (AOR, 19.155; 95% CI: 2.337-157.018; P = 0.006 and AOR, 9.629; 95% CI: 1.053-88.013; P = 0.045, respectively).
Conclusion:
Prior carbapenem use is a significant risk factor for developing S. maltophilia BSIs. PICU admission because of BSI and prior glycopeptide use are risk factors associated with the mortality rate in patients with S. maltophilia BSIs. Therefore, S. maltophilia should be considered in patients with these risk factors, and empirical treatment should include antibiotics for S. maltophilia .
Insights
Prior carbapenem use increases the risk of Stenotrophomonas maltophilia bloodstream infections (BSIs) in children. Previous Pediatric Intensive Care Unit admission and glycopeptide use are risk factors for S. maltophilia BSI mortality.
Area of Science:
- Pediatric Infectious Diseases
- Clinical Microbiology
- Critical Care Medicine
Background:
- Stenotrophomonas maltophilia (S. maltophilia) infections are increasingly concerning due to high fatality rates.
- Understanding risk factors for S. maltophilia bloodstream infections (BSIs) in children is crucial for effective management.
Purpose of the Study:
- To evaluate risk factors for S. maltophilia BSIs in children.
- To identify risk factors associated with mortality in pediatric S. maltophilia BSIs.
- To compare S. maltophilia BSIs with Pseudomonas aeruginosa BSIs.
Main Methods:
- Retrospective analysis of 73 S. maltophilia and 80 Pseudomonas aeruginosa BSIs from January 2014 to December 2021.
- Comparison of patient demographics, clinical characteristics, and treatment outcomes.
- Multivariate analysis to identify independent risk factors for infection and mortality.
Main Results:
- Prior Pediatric Intensive Care Unit (PICU) admission, glycopeptide, and carbapenem use were more frequent in S. maltophilia BSIs.
- Higher C-reactive protein (CRP) levels were observed in S. maltophilia BSIs.
- Prior carbapenem use (AOR: 2.710) and PICU admission (AOR: 19.155) with prior glycopeptide use (AOR: 9.629) were significant risk factors for S. maltophilia BSI and mortality, respectively.
Conclusions:
- Prior carbapenem use is a significant risk factor for S. maltophilia BSIs in children.
- PICU admission and prior glycopeptide use are associated with increased mortality in pediatric S. maltophilia BSIs.
- Empirical antibiotic treatment should consider S. maltophilia in high-risk patients.
More Related Videos
07:46Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
Published on: June 5, 2012
05:03Visualizing the Effects of Sputum on Biofilm Development Using a Chambered Coverglass Model
Published on: December 14, 2016
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Pneumonia III: Complications and Assessment